Section Arrow
OCX.NASDAQ
- Oncocyte Corp
Quotes are at least 15-min delayed:2024/11/16 10:05 EST
Last
 2.61
-0.19 (-6.79%)
Day High 
2.79 
Prev. Close
2.8 
1-M High
3.26 
Volume 
57.29K 
Bid
2.52
Ask
3
Day Low
2.6 
Open
2.74 
1-M Low
2.7 
Market Cap 
37.43M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.9 
20-SMA 2.99 
50-SMA 3.03 
52-W High 4.34 
52-W Low 2.285 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.24/-0.31
Enterprise Value
39.64M
Balance Sheet
Book Value Per Share
1.70
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.50M
Operating Revenue Per Share
0.17
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
OPKOPKO Health1.64+0.02+1.23%-- 
DHRDanaher Corp230.5-8.88-3.71%44PE
ILMNIllumina135.05-7.19-5.05%-- 
IQVIQVIA Holdings192.68-10.26-5.06%26.6PE
TMOThermo Fisher Scientific513.08-19.94-3.74%33.07PE
Quotes are at least 15-min delayed:2024/11/16 10:05 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.